سعر Somazina 100mg/ml oral drops 30 ml 2026

Somazina oral drops 30 ml is a citicoline 100 mg/ml oral liquid listed in Egypt by October Pharma under licence from Ferrer Internacional (Spain).

• Neurological and cognitive disorders associated with stroke.Population: AdultsCIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
• Neurological and cognitive disorders associated with head trauma.Population: AdultsCIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• Very rare (<1/10,000): hallucinations; headache, vertigo; hypertension or hypotension; dyspnoea; nausea, vomiting, occasional diarrhoea; flushing, urticaria, rash, purpura; chills, oedema.International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• Hypersensitivity to citicoline or any excipient.International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
• Patients with hypertonia of the parasympathetic nervous system.International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• The Spanish oral solution contains Ponceau 4R (E124; may cause allergic reactions and asthma, especially in aspirin-allergic patients), sorbitol (200 mg/ml; not for hereditary fructose intolerance), methyl/propyl parahydroxybenzoates (possibly delayed allergy) and glycerol formal (may cause stomach upset and diarrhoea). Excipients of the Egyptian product were not verified.International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• Levodopa-containing medicinesCiticoline potentiates the effects of L-dopa-containing medicines.CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
• Meclofenoxate (centrophenoxine)Citicoline should not be given together with medicines containing meclofenoxate (centrophenoxine).CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• There are insufficient data on citicoline use in pregnant women; it should not be used in pregnancy unless clearly necessary (benefit outweighs possible risk).International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• Citicoline: Stimulates biosynthesis of structural neuronal-membrane phospholipids, inhibits activation of some phospholipases (A1, A2, C, D), reduces free-radical formation and stimulates acetylcholine synthesis (Spanish Somazina SmPC section 5.1).